Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 595 (ZNF595) is a member of the Cys2His2 zinc finger protein family, which predominantly function as transcription factors involved in regulating gene expression, often by binding DNA and modulating transcriptional activity[1][2][4][5][6]. The protein may play a role in negative regulation of gene expression and transcriptional regulation by RNA polymerase II[2][6]. There is currently no evidence in authoritative databases to indicate that ZNF595 is a validated therapeutic target, nor any established links to disease processes, biomarkers, or drug interactions[1][2][4][5][6]. Key points: - No evidence supports its use as a therapeutic target, biomarker, or known disease association in public databases[1][2][4][5][6]. - ZNF595 is categorized as a transcription factor due to its domain structure and predicted function but lacks further characterization in clinical or pharmacological contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 595 (ZNF595).